Literature DB >> 7945772

Deceptive imprinting in the immune response against HIV-1.

H Köhler1, S Müller, P L Nara.   

Abstract

The clonal profile of anti-HIV-1 antibodies is established at the time of infection as part of a vigorous immune response against HIV-1, and remains stable during the infection process. This bias towards antibodies specific for the initially infecting clonal virus population, termed imprinting, is inappropriate for attempts of the infected host to control viral variants that subsequently emerge. Here, Heinz Köhler, Sybille Müller and Peter Nara argue that immunodominant epitopes on viral variants or recombinant proteins are selected that induce and maintain this deceptive state, and thereby remain unrecognized through a functional and cross-reactive hole in the B-cell repertoire.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945772     DOI: 10.1016/0167-5699(94)90192-9

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  12 in total

1.  Additive effect of neutralizing antibody and antiviral drug treatment in preventing virus escape and persistence.

Authors:  P Seiler; B M Senn; P Klenerman; U Kalinke; H Hengartner; R M Zinkernagel
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Cross-reactive T-cell proliferative responses to V3 peptides corresponding to different geographical HIV-1 isolates in HIV-seropositive individuals.

Authors:  P N Nehete; P C Johnson; S J Schapiro; R B Arlinghaus; K J Sastry
Journal:  J Clin Immunol       Date:  1996-03       Impact factor: 8.317

3.  Short communication: antibody responses to human immunodeficiency virus envelope from infections with multiple subtypes utilize the 1F7-idiotypic repertoire.

Authors:  Matthew S Parsons; Robert J Center; Jean-Pierre Routy; Danielle Rouleau; Roger Leblanc; Mark A Wainberg; Cécile L Tremblay; Marcel D Zannou; Stephen J Kent; Michael D Grant; Nicole F Bernard
Journal:  AIDS Res Hum Retroviruses       Date:  2013-01-29       Impact factor: 2.205

4.  Hepatitis C virus serotype-specific core and NS4 antibodies in injecting drug users participating in the Amsterdam cohort studies.

Authors:  M Beld; M Penning; M van Putten; A van den Hoek; V Lukashov; M McMorrow; J Goudsmit
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

5.  Stimulation of HIV-1-neutralizing antibodies in simian HIV-IIIB-infected macaques.

Authors:  S Müller; D H Margolin; P L Nara; W G Alvord; H Köhler
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

6.  Xenoepitope substitution avoids deceptive imprinting and broadens the immune response to foot-and-mouth disease virus.

Authors:  Steven M Szczepanek; Roger W Barrette; Debra Rood; Diana Alejo; Lawrence K Silbart
Journal:  Clin Vaccine Immunol       Date:  2012-02-08

7.  Live-virus exposure of vaccine-protected macaques alters the anti-HIV-1 antibody repertoire in the absence of viremia.

Authors:  Barbara C Bachler; Michael Humbert; Samir K Lakhashe; Robert A Rasmussen; Ruth M Ruprecht
Journal:  Retrovirology       Date:  2013-06-21       Impact factor: 4.602

8.  How can vaccines against influenza and other viral diseases be made more effective?

Authors:  Peter L Nara; Gregory J Tobin; A Ray Chaudhuri; Jessie D Trujillo; George Lin; Michael W Cho; Simon A Levin; Wilfred Ndifon; Ned S Wingreen
Journal:  PLoS Biol       Date:  2010-12-21       Impact factor: 8.029

Review 9.  Multiantibody strategies for HIV.

Authors:  Andrew Hiatt; Larry Zeitlin; Kevin J Whaley
Journal:  Clin Dev Immunol       Date:  2013-06-06

10.  Characterization of conserved properties of hemagglutinin of H5N1 and human influenza viruses: possible consequences for therapy and infection control.

Authors:  Veljko Veljkovic; Nevena Veljkovic; Claude P Muller; Sybille Müller; Sanja Glisic; Vladimir Perovic; Heinz Köhler
Journal:  BMC Struct Biol       Date:  2009-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.